HONG KONG, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market. MicuRx Pharmaceuticals issued 130,000,000 shares this time, accounting for 19.84% of the total share capital after […]

HONG KONG, Jul 21, 2022 – (ACN Newswire via SEAPRWire.com) – On July 21st, 2022, Lunit, a leading global AI-based cancer solutions provider invested by Legend Capital, was successfully listed on the KOSDAQ market. Founded in 2013, Lunit successfully established itself as the world’s top-notch artificial intelligence technology solution provider, […]

HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – On June 14, two of Legend Capital’s portfolio companies, Innovent Biologics, Inc. (“Innovent”) and PT Etana Biotechnologies Indonesia (“Etana”), jointly announced that the Indonesian Food and Drugs Authority (BPOM) had approved Bevagen (bevacizumab biosimilar), a recombinant humanized anti-VEGF monoclonal […]

HONG KONG, Apr 24, 2022 – (ACN Newswire via SEAPRWire.com) – Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application of its product LX101 injection for the treatment of patients with Rpe65 biallelic mutation-associated inherited retinal degenerations (IRD) was […]

HONG KONG, Apr 1, 2022 – (ACN Newswire via SEAPRWire.com) – According to South China Morning Post, Global market experienced another rock year. The impact of COVID-19 still not got away, the chaos of global supply chain showed that the world still need time to recover; the aftermath of geopolitical […]

HONG KONG, Mar 31, 2022 – (ACN Newswire via SEAPRWire.com) – Legend Holdings Corporation (3396.HK) announced today the audited annual results of the 12 months ended December 31, 2021(“Reporting Period”). In 2021, the Company’s revenue was RMB489.872 billion, representing a year-on-year increase of 17%; net profit attributable to equity holders […]

HONG KONG, Oct 8, 2021 – (ACN Newswire via SEAPRWire.com) – ForQaly Medical (hereinafter referred to as “ForQaly”), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused on developing micro-traumatic circulatory assistant devices. Recently, it completed its Series B fundraising led by Legend Capital, followed by […]

HONG KONG, Sep 14, 2021 – (ACN Newswire via SEAPRWire.com) – Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM). This round of funds will be used to […]

HONG KONG, Sep 1, 2021 – (ACN Newswire via SEAPRWire.com) – Legend Holdings Corporation (“Legend Holdings” or the “Company”; stock code: 3396.HK) announced the unaudited interim results of the six months ended June 30, 2021 (the “Reporting Period”) on August 31, 2021. During the Reporting Period, the Company’s revenue was […]